Document is current
Any future updates will be listed below
-
Authors
,
Tosco, Lorenzo
Laenen, Annouschka
Gevaert, Thomas
Salmon, Isabelle
Decaestecker, Christine
Davicioni, Elai
Buerki, Christine
Claessens, Frank
Swinnen, Johan
Goffin, Karolien
Oyen, Raymond
Everaerts, Wouter
Moris, Lisa
De Meerleer, Gert
Haustermans, Karin
Joniau, Steven
-
Funding
Funding for this research was provided by:
Janssen Pharmaceuticals
Ferring Pharmaceuticals
Leuven Cancer Institute
Fonds Yvonne Boël
European Regional Development Fund and the Walloon Region
- License Information
-
More Information
Article History
Received: 22 August 2017
Accepted: 21 March 2018
First Online: 2 April 2018
Ethics approval and consent to participate
: Medical Ethics Committee UZ KU Leuven / Research.
: LT an SJ consent for publication of this article considering that similar content was available in the PhD thesis of LT (ISBN-NUMBER: 9789082757606 for the printed version and 9,789,082,757,613 for the e-version).
: LT: research grants from Bayer, Ipsen, Ferring, Janssen; Consulting or Advisory Role for Ipsen. Travel, Accomodation, Expenses from Astellas, Bayer and Pierre-Fabre. WE: Consulting fees: Bayer, Janssen; Travel, Accomodation, Expenses from Astellas. SJ: Research grants from Bayer, Ipsen, Ferring, Janssen; Honoraria from Bayer, Ferring, Astellas, Ipsen, Janssen. Travel, Accomodation, Expenses from Bayer, Ferring, Astellas, Ipsen, Janssen. ED: employee and stockholder of GenomeDx makers of Decipher. CB: employee and stockholder of GenomeDx makers of Decipher.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
